AMBOSS says “Patient race: For Black patients (including individuals with diabetes) without CHE or CKD, initial antihypertensive therapy. should include a thiazide-type diuretic or CCB.” Then in the text bubble says: Previous guidelines have recommended using only diuretics or CCBs to treat hypertension in Black patients without CKD. These recommendations have been criticized for multiple reasons, including making the incorrect assumption that all Black individuals are “salt-sensitive” with low renin levels and therefore particularly responsive to diuretics, and for denying Black patients the potential benefits of renin-angiotensin-aldosterone system inhibitors. Although not explicitly recommended by current US guidelines, experts have advised that a combination medication is a reasonable strategy for Black patients. The 2020 ISH guideline recommends the combination of a CCB and either a thiazide-type diuretic or an ARB.
Added #deck-AnKing Overhaul for Step 1 & 2-AnKingMed and removed #deck-anking-overhaul-for-step-1–2-ankingmed
Appreciate the points raised here but this card reflects current treatment guidelines that students are likely to be tested on, so we will need to keep as is until those change